Maria Arantxa Horga

Insider Reports History

Entity
Individual
Location
C/O Atea Pharmaceuticals, Inc., 125 Summer Street, Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Maria Arantxa Horga
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maria Arantxa Horga:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Chief Medical Officer Restricted Stock Units 83.1K $319K $3.84 Jan 31, 2024 Direct
Atea Pharmaceuticals, Inc. Chief Medical Officer Common Stock 25.7K $98.6K $3.84 Feb 1, 2024 Direct
Atea Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 193K Jan 31, 2024 Direct

Insider Reports Filed by Maria Arantxa Horga

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2024 4 -$61K 4 Feb 2, 2024 Chief Medical Officer
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 Chief Medical Officer
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 Chief Medical Officer